Use, intentions, and beliefs about hormone replacement therapy in women with and without diabetes

Maturitas

Volumn 55, Issue 1, 2006, Pages 58-68

  Huston, Sally A ^a   Kirking, Duane M ^b   Shimp, Leslie A ^b  

^a SOUTHERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Beliefs; Diabetes; Hormone replacement therapy; HRT; Menopause

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE DISTRIBUTION; DIABETES MELLITUS; FEMALE; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MENOPAUSE; MICHIGAN; MIDDLE AGED; QUESTIONNAIRES;

EID: 33746257214     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.01.004     Document Type: Article

References (43)

1. Watkins E.S. Dispensing with aging: changing rationales for long-term hormone replacement therapy, 1960-2000. Pharm Hist 43 (2001) 23-37
2. American College of Obstetricians and Gynecologists. American College of Obstetricians and Gynecologists educational bulletin: hormone replacement therapy. Am Coll Obstetricians Gynecologists 247 (1998) 1-10
3. Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians. Ann Inter Med 1992;117(12):1038-1041.
4. U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 2nd ed. (1996), Williams & Wilkins, Baltimore
5. Austin P.C., Mamdani M.M., Tu K., and Jankiimainen L. Research letter. Prescriptions for estrogen replacement therapy in Ontario before and after publication of the women's health initiative study. JAMA 289 (2003) 3241-3242
6. Whitlock E.P., Johnson R.E., and Vogt T.M. Recent patterns of hormone replacement therapy use in a large managed care organization. J Women's Health 7 (1998) 1017-1026
7. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., and Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280 7 (1998) 605-613
8. Writing Group for the Women's Health Initiative. Investigators risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288 (2002) 321-333
9. Hersh A.L., Stefanick M.L., and Stafford R.S. National use of postmenopausal hormone therapy. Annual trends and response to recent evidence. JAMA 291 (2004) 47-53
10. Barrett-Connor E, Hendrix S, Ettinger B, et al. Best Clinical Practices. Chapter 13 from the International Position Paper on Women's Health and Menopause: A Comprehensive Approach. National Heart, Lung, and Blood Institute, National Institutes of Health Office of Research on Women's Health, and Giovanni Lorenzini Medical Science Foundation. 2002. http://www4.od.nih.gov/orwh/. Access date: 5-27-2002.
11. The North American Menopause Society, Alternatives to Hormone Replacement Therapy: Suggestions from The North American Menopause Society; 2002. http://www.menopause.org/alternatives_hrt.html. Access date: 10-23-2002.
12. Kaplan S. A model of person-environment compatibility. Environ Behav 15 (1983) 311-332
13. Keating N.L., Cleary P.D., Rossi A.S., Zaslavskky A.M., and Ayanian J.Z. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Inter Med 130 (1999) 545-553
14. Redelmeier D.A., Tan S.H., and Booth G.L. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 338 (1998) 1516-1520
15. Robinson J.G., Folsom A.R., Nabulsi A.A., Watson R., Brancati F.L., and Cai J. Can postmenopausal hormone replacement improve plasma lipids in women with diabetes?. Diabetes Care 19 (1996) 480-485
16. Stafford R.S., Saglam D., Causino N., and Blumenthal D. Low rates of hormone replacement in visits to United States primary care physicians. Am J Obstet Gynecol 177 (1997) 381-387
17. North American Menopause Society. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of the North American menopause society. Menopause: J North Am Menopause Soc 7 (2000) 87-95
18. Kaplan R.C., Heckbert S.R., Weiss N.S., et al. Postmenopausal estrogens and risk of myocardial infarction in diabetic women. Diabetes Care 21 (1998) 1117-1121
19. Lawrenson R.A., Leydon G.M., Newson R.B., and Feher M.D. Coronary heart disease in women with diabetes: positive association with past hysterectomy and possible benefits of hormone replacement therapy. Diabetes Care 22 (1999) 856-857
20. Lobo R.A. Estrogen and cardiovascular disease. Ann N Y Acad Sci 592 (1990) 272-285
21. Nabulsi A.A., Folsom A.R., White A., et al. Association of hormone-replacement therapy with various cardiovascular risk factors in post-menopausal women: the atherosclerosis risk in communities study investigators. N Engl J Med 328 (1993) 1069-1075
22. Stampfer M.J., and Colditz G.A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prevent Med 20 (1991) 47-63
23. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329 (1993) 977-986
24. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
25. Steil C.F. Diabetes mellitus. In: DiPiro J.T., Talbert R.L., Yee G.C., et al. (Eds). Pharmacotherapy: a pathophysiologic approach (1999), Appleton and Lange, Stamford, CT 1219-1243
26. Krakauer J.C., McKenna M.J., Buderer N.F., Rao D.S., Whitehouse F.W., and Parfitt A.M. Bone loss and bone turnover in diabetes. Diabetes 44 (1995) 775-782
27. Sayinalp S., Gedik O., and Koray Z. Diabetic osteopenia: pathophysiology and clinical aspects. Diab Metab Rev 11 (1995) 21-35
28. Dunne F.P. Should women with diabetes mellitus receive hormone replacement therapy?. Int J Clin Pract 51 (1997) 299
29. Espeland M.A., Hogan P.E., Fineberg S.E., et al. PEPI investigators effect of postmenopausal hormone therapy on glucose and insulin concentrations. Diabetes Care 21 (1998) 1589-1595
30. Ferrara A., Barrett-Connor E., Wingard D.L., and Edelstein S.L. Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status: the Rancho Bernardo study, 1984-1987. Diabetes Care 18 (1995) 220-225
31. Manson J.E., Rimm E.B., Colditz G.A., et al. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus. Ann Epidemiol 2 (1992) 665-673
32. Phillips P. Diabetes and the menopause. Aust Fam Physician 27 (1998) 59-63
33. Huston S.A., Sleath B., and Rubin R.H. Physician gender and hormone replacement therapy discussion. J Women's Health Gender-Based Med 10 (2001) 279-287
34. Garamszegi C., Dennerstein E., Dudley E., Guthrie J.R., Ryan M., and Burger H. Menopausal status: subjectively and objectively defined. J Psychosom Obstet Gynaecol 19 (1998) 165-173
35. Sparks P., Guthrie C.A., and Shepherd R. The dimensional structure of the perceived behavioral control construct. J Appl Soc Psychol 27 (1997) 418-438
36. Dillman D.A. Mail and internet surveys. The tailored design method. 2nd ed. (2000), John Wiley & Sons, Inc., New York
37. Montano DE, Kasprzyk D. The theory of reasoned action and the theory of planned behavior. In: Glanz K, Rimer BK, Lewis FM, editors. Health behavior and health education. 3rd ed. San Francisco: Jossey-Bass; 2002. p. 67-98 [chapter 4].
38. Spatz B.A., Denis L.T., Byrne J., and Page B.J. Use of the theory of planned behavior to explain HRT decisions. Am J Health Behav 27 (2003) 445-455
39. Levens E., and Williams S. Current opinions and understandings of menopausal women about hormone replacment therapy (HRT)-The University of Floriday experience. Am J Obstet Gynecol 191 (2004) 641-647
40. Visser A.P., Hofland I., Gehring B., et al. The continuation of hormone replacement therapy: a compliance study of Dutch and Belgian climacteric women. J Reprod Infant Psychol 13 (1995) 135-146
41. Svenson O. Differentiation and consolidation theory of human decision making: a frame of reference for the study of pre- and post-decision processes. Acta Psychol 80 (1992) 143-168
42. O'Keefe D.J. Persuasion: theory & research. 2nd ed. (2002), Sage, Thousand Oaks
43. Legato M.J., Emrika P., and Slaughter E. Women's perceptions of their general health, with special reference to their risk of coronary artery disease: results of a national telephone survey. J Women's Health 6 (1997) 189-198